CrowdStrike Holdings, Inc. ⋅ 10-Q ⋅ 6/4 CIENA CORP ⋅ 10-Q ⋅ 6/4 Keysight Technologies, Inc. ⋅ 10-Q ⋅ 6/4 DICK'S SPORTING GOODS, INC. ⋅ 10-Q ⋅ 6/4 lululemon athletica inc. ⋅ 10-Q ⋅ 6/4 PERSHING SQUARE INC. ⋅ 10-Q ⋅ 6/4 FIVE BELOW, INC ⋅ 10-Q ⋅ 6/4 X-Energy, Inc. ⋅ 10-Q ⋅ 6/4 ARGAN INC ⋅ 10-Q ⋅ 6/4 TORO CO ⋅ 10-Q ⋅ 6/4

CrowdStrike Holdings, Inc. ⋅ 10-Q ⋅ 6/4 CIENA CORP ⋅ 10-Q ⋅ 6/4 Keysight Technologies, Inc. ⋅ 10-Q ⋅ 6/4 DICK'S SPORTING GOODS, INC. ⋅ 10-Q ⋅ 6/4 lululemon athletica inc. ⋅ 10-Q ⋅ 6/4 PERSHING SQUARE INC. ⋅ 10-Q ⋅ 6/4 FIVE BELOW, INC ⋅ 10-Q ⋅ 6/4 X-Energy, Inc. ⋅ 10-Q ⋅ 6/4 ARGAN INC ⋅ 10-Q ⋅ 6/4 TORO CO ⋅ 10-Q ⋅ 6/4

GH Research PLC

Pharmaceutical Preparations | SIC: 2834
Phone: 353 1 437 8334

CIK: 0001855129
State Location: L2
State of Inc.: L2

Nasdaq:GHRS

Form: SCHEDULE 13G/A

Filing Date: 14 Nov 2025
Report Date:
Accepted: 14 Nov 2025 07:13 p.m.
Accession Number: 0001909586-25-000007

Act: 34
File Number: 005-92661
Film Number: 251486311

Documents

Primary Document

Accepted: 14 Nov 2025 07:13 p.m.

0001909586-25-000007-index-headers.html

Last Modified: 14 Nov 2025 02:13 p.m.

0001909586-25-000007-index.html

Last Modified: 14 Nov 2025 02:13 p.m.

0001909586-25-000007.txt

Last Modified: 14 Nov 2025 02:13 p.m.

primary_doc.xml

Last Modified: 14 Nov 2025 02:13 p.m.